Clik here to view.
Don’t Delay Affordable Healthcare
President Obama’s plan for lowering the cost of healthcare relies partly on ensuring that affordable generic drugs are available to patients. This strategy is not likely to be palatable to innovator...
View ArticleClik here to view.
Pfizer Fights Transparency
Patients rely on doctors to make impartial decisions about the most effective treatments for their conditions. In recent years, public advocates have agitated for restrictions on pharmaceutical...
View ArticleClik here to view.
AstraZeneca: Unwitting Advocate for Disclosure?
Healthcare-reform legislation is not the only federal initiative that is affecting pharmaceutical manufacturers these days. US Attorney General Eric Holder is cracking down on healthcare fraud,...
View ArticleClik here to view.
Pharma Accused Of Misleading Regulators
“The pharmaceutical industry is a ‘market for lemons’; a market in which the seller knows much more than the buyer about the product and can profit from selling products less effective and less safe...
View ArticleClik here to view.
More Japanese Interest in Potential Obesity Drugs
Last week, Japanese drugmaker Takeda (Osaka, Japan) struck a deal with biopharmaceutical company Orexigen (La Jolla, CA) for the commercialization of its investigational obesity drug Contrave...
View ArticleClik here to view.
Knowing When to Stay the Blade
Concern about the federal government’s budget deficit is reaching a crescendo. Assorted Cassandras warn that failing to address this problem could have dire consequences, and members of both parties...
View ArticleWinds of Change at the International Society of Automation Summit
The International Society of Automation’s (ISA’s) 7th Marketing and Sales Summit, held Aug. 15–17, 2012 in Austin, Texas, was themed “New Rules of Customer Engagement: Riding the Winds of Change”, and...
View ArticleHow Post-Market Feedback Can Influence Compliance when Using a Quality...
Guest blog by Tim Lozier. In most industries, businesses run the same way. You can either stick your head in the sand and pretend that everything is going fine, or you can stand up and take the...
View ArticleClik here to view.
Colored Brain Sparks FDA Warning Letter
Warning Letters are a fact of life for the pharmaceutical industry and it can be difficult to avoid them. Not only are warning letters issued by FDA for cGMP deficiencies, letters can also be initiated...
View ArticleAdvancing Pharma’s Social Media Listening Analytics
Guest blog by Ben Comer of Pharmaceutical Executive. The pharmaceutical industry still lags other industries in spending on outbound social media programs that engage customers directly, but they are –...
View Article
